Vaborbactam
Research stageAlso known as Vabomere.
Recent clinical, regulatory, research and industry developments relating to this drug.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Molecules (Basel, Switzerland)1
- Pregnolato M1
- Taccani M1
- Terreni M1
- University of Pavia1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Vaborbactam in the shared literature.
Studied across 2 of the same disease areas as Vaborbactam in the shared literature.
Studied across 2 of the same disease areas as Vaborbactam in the shared literature.
Studied across 2 of the same disease areas as Vaborbactam in the shared literature.
Studied across 2 of the same disease areas as Vaborbactam in the shared literature.
Studied across 2 of the same disease areas as Vaborbactam in the shared literature.
Studied across 2 of the same disease areas as Vaborbactam in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature